Song F.-R.,Weifang Medical University |
Cheng H.,The East District of Qingdao Municipal Hospital |
Zhao D.-M.,The East District of Qingdao Municipal Hospital |
Yu J.,The East District of Qingdao Municipal Hospital |
Gao Y.,The East District of Qingdao Municipal Hospital
Chinese Journal of Evidence-Based Medicine | Year: 2014
Objective To explore and discuss the Effects of lanthanum carbonate on serum calcium and phosphorus of continuous ambulatory peritoneal dialysis (CAPD) patients with chronic renal failure receiving calcitriol pulse therapy due to secondary hyperparathyroidism (SHPT). Methods CAPD patients caused by SHPT in peritoneal dialysis centre of the Qingdao Municipal Hospital of Eastern Hospital from March to June, 2013 were selected and randomly divided into two groups (lanthanum carbonate group and calcium carbonate group). The lanthanum carbonate group were treated with oral lanthanum carbonate and calcitriol pulse therapy, while the calcium carbonate group were treated with calcium carbonate and calcitriol. Change of levels of serum calcium, phosphorus and iPTH were observed and statistic analysis was conducted using SPSS 17.0. Results A total of 40 CAPD patients were included, 20 cases in each group. After 12-week treatment, levels of serium phosphate (t=5.095, P=0.000) and iPTH (t=1.225, P=0.000) in the lanthanum carbonate group were significantly lower than those before treatment. The levels of serum calcium (t=1.127, P=0.001) and phosphate (t=2.035, P=0.000) in the lanthanum carbonate group were significantly lower than those in the calcium carbonate group (P<0.05). Conclusion Lanthanum carbonate serves as a useful approach to improve hypercalcemia and the hyperphos-phatemia in CAPD patients receiving calcitriol pulse therapy due to SHPT. © 2014 Editorial Board of Chin J Evid-based Med.